-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on CASI Pharmaceuticals, Maintains $4 Price Target

Benzinga·05/19/2025 10:43:39
Listen to the news
HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price target.